about
Pharmacological treatment options for mast cell activation diseasePalmitoylethanolamide, a Natural Retinoprotectant: Its Putative Relevance for the Treatment of Glaucoma and Diabetic RetinopathyPalmitoylethanolamide for the treatment of pain: pharmacokinetics, safety and efficacyThe pharmacology of palmitoylethanolamide and first data on the therapeutic efficacy of some of its new formulations.Palmitoylethanolamide induces microglia changes associated with increased migration and phagocytic activity: involvement of the CB2 receptorPalmitoylethanolamide inhibits glutamate release in rat cerebrocortical nerve terminalsBeneficial Effects of Palmitoylethanolamide on Expressive Language, Cognition, and Behaviors in Autism: A Report of Two Cases.Anti-Inflammatory, Antioxidant and Crystallographic Studies of N-Palmitoyl-ethanol Amine (PEA) Derivatives.Acetylcholine receptors from human muscle as pharmacological targets for ALS therapy.Acetaminophen Use for Fever in Children Associated with Autism Spectrum DisorderAre big potassium-type Ca(2+)-activated potassium channels a viable target for the treatment of epilepsy?Circulating Endocannabinoids: From Whence Do They Come and Where are They Going?Beneficial Effects of Co-Ultramicronized Palmitoylethanolamide/Luteolin in a Mouse Model of Autism and in a Case Report of Autism.Palmitoylethanolamide Modulates GPR55 Receptor Signaling in the Ventral Hippocampus to Regulate Mesolimbic Dopamine Activity, Social Interaction, and Memory Processing.A novel crosstalk within the endocannabinoid system controls GABA transmission in the striatum.Anti-Inflammatory and Neuroprotective Effects of Co-UltraPEALut in a Mouse Model of Vascular Dementia.Palmitoylethanolamide Supplementation during Sensitization Prevents Airway Allergic Symptoms in the Mouse.Palmitoylethanolamide Blunts Amyloid-β42-Induced Astrocyte Activation and Improves Neuronal Survival in Primary Mouse Cortical Astrocyte-Neuron Co-Cultures.Antiepileptogenic Effect of Subchronic Palmitoylethanolamide Treatment in a Mouse Model of Acute Epilepsy.An Inflammation-Centric View of Neurological Disease: Beyond the Neuron.Endocannabinoids and related -acylethanolamines: biological activities and metabolism
P2860
Q26748784-321C3F23-A513-493E-987E-B00656B24EFCQ26776171-1CB80812-CCB7-46B4-9A46-E57656B74B79Q28066248-5CD05357-45CF-49E1-A55F-338CF8D5DA2DQ31122398-D2E94675-3056-46BE-AE28-22EC29EA080AQ33671206-2FB6FCFA-8E6F-4373-A47F-2F133973743AQ35381177-44C2B9A9-235E-41C8-B0F0-5D35A1CC9C83Q36150334-01391CDE-EC0B-44BB-AA39-8A8AC7AAD6B2Q36343053-D4DD99BB-BEB4-441E-8D91-6321B1EFBC51Q36710671-E8A85244-687D-4011-A672-414C3F177251Q37300512-16418E5B-A4B1-459F-8709-FCD2CC680D21Q38404580-38FE2E76-89D3-4DF2-A31D-13ACEA78C2A7Q38707482-AD17D4DB-7440-4142-BB36-F78F62DB0728Q39324090-AB451529-4B0C-4AF0-B4B5-A3DA0985AC2CQ41152448-0B42C4F3-77A2-40FD-862A-D0A7E220E191Q41260178-3625D985-4677-40B4-B2A6-FA4FAC9FCCA1Q42220056-A7F5644B-EECC-441F-8861-37D4CA6965C5Q47222146-FD3FF044-EB76-4946-B5F7-F1983F1CACB6Q47962439-902135EF-3555-4453-955E-B54379E3E7E3Q52316988-DD3AF79C-7F46-4E5D-A0F9-2873752C431FQ52331711-672ECEC1-C13E-4B7D-A096-89AD31B4667CQ57055931-56318775-A5D0-4C87-B1A1-99938BC63F70
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Palmitoylethanolamide in CNS health and disease.
@en
type
label
Palmitoylethanolamide in CNS health and disease.
@en
prefLabel
Palmitoylethanolamide in CNS health and disease.
@en
P50
P1476
Palmitoylethanolamide in CNS health and disease.
@en
P2093
Roberto Russo
P356
10.1016/J.PHRS.2014.05.006
P577
2014-05-17T00:00:00Z